Shilpa Medicare has received GMP Certification from AGES, Austria for its Unit 4, Jadcherla, Telangana, India, following a successful inspection. AGES, Austria had conducted inspection at the said facility from July 27, 2026 to July 30, 2026.
This Unit of Shilpa Medicare is engaged in the manufacturing, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in Europe and rest of the world markets.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
